DNTT and acute lymphoblastic leukemia: Overexpression of these TdT isoforms in cancerous (acute lymphoblastic leukemia/lymphoma, ALL) cells, emphasizing the importance of investigating the structural aspects of TdT and provide pointers for drug design [4–6].